Maryland, Virginia, Washington, D.C., and Philadelphia
Good morning! This week we follow up with a handful of Human Genome Sciences alumni to see what they've accomplished since GSK acquired the company in 2012. We also share the scoop on UM BioPark's newest project to provide much-needed lab space to Baltimore, NextCure's new in-house GLP lab, and more. Read on!
HGS alumni recently gathered to celebrate the 10th anniversary of the GSK acquisition at an alumni reunion event sponsored by Kymanox and BioIT Solutions, two... Read More
Slated for opening in 2024, 4MLK is Phase 1 of a two-phase project representing a $320 million total capital investment at the BioPark that will deliver 160,000 square... Read More
With the economy teetering on recession and global forces like high inflation, supply chain challenges and war making volatility the norm, even the biotech industry, which... Read More
Every successful and growing biotech arrives at the same crossroads eventually: to outsource or build in-house. That becomes the critical question—the fact that this... Read More
AMPEL Biosolutions (AMPEL), located in Charlottesville, Virginia is a leading personalized precision medicine company developing tools that can help... Read More
A new biotech life sciences building, poised to be a solution for a multitude of companies, is coming to Germantown. Guardian Realty Investors has created... Read More
The Vice President Clinical Development is a key member of the clinical team and will report directly to the Chief Medical Officer. Under the supervision of the Chief Medical Officer, the Vice President Clinical Development utilizes their therapeutic knowledge of oncology and solid tumors and/or related expertise to... Read More
We are seeking a highly motivated and passionate individual to join our Summer Internship Program! As an intern at Kite, you’ll have the unique opportunity to learn about cell therapy from some of the brightest minds in biotech while making a meaningful impact. We’re committed to developing early talent, and we welcome... Read More
The Director, Quality Assurance Client Services & Batch Disposition is responsible for managing clinical and commercial manufacturing projects for the QA department, overseeing the batch disposition process, QA aspect of analytical review, and assessing quality-related issues and ensuring compliance with... Read More
Maryland means big opportunities for medtech innovators. And 20 of those medtech innovators are putting their technology, and the power of our booming medtech community, on display for the world... Read More
BioFactura Inc. has announced today the completion of the pivotal pharmacokinetic comparability clinical trial for its Ustekinumab Biosimilar (BFI-751). The clinical trial was conducted in two sites in... Read More
Gilead Sciences, Inc. (NASDAQ: GILD) and MacroGenics (NASDAQ: MGNX) today announced an exclusive option and collaboration agreement to develop MGD024, an investigational, bispecific antibody... Read More
TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Funds invested $200,000 in CoolTech, LLC, a Maryland-based medical device start-up. TEDCO’s Seed... Read More
Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therapies to treat muscular dystrophies and cancers, today announced the completion of a $31 million Series B financing.The fundraise... Read More
Come join us for a virtual event with Dr. Laundette Jones and learn about Biosocial research. Which is concerned with the dynamic interplays between biology, experiences, and behaviors... Read More
Join us on October 26th from 10:00 a.m. to 4:00 p.m. at Montgomery College and learn how to Drive Your Flow Forward with the CytoFLEX* flow cytometry platform. We plan on... Read More